» Articles » PMID: 39229465

A 10-year Retrospective Cohort of Diabetic Patients in a Large Medical Institution: Utilizing Multiple Machine Learning Models for Diabetic Kidney Disease Prediction

Overview
Journal Digit Health
Date 2024 Sep 4
PMID 39229465
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: As the prevalence of diabetes steadily increases, the burden of diabetic kidney disease (DKD) is also intensifying. In response, we have utilized a 10-year diabetes cohort from our medical center to train machine learning-based models for predicting DKD and interpreting relevant factors.

Methods: Employing a large dataset from 73,101 hospitalized type 2 diabetes patients at The First Affiliated Hospital of Zhengzhou University, we analyzed demographic and medication data. Machine learning models, including XGBoost, CatBoost, LightGBM, Random Forest, AdaBoost, GBDT (gradient boosting decision tree), and SGD (stochastic gradient descent), were trained on these data, focusing on interpretability by SHAP. SHAP explains the output of the models by assigning an importance value to each feature for a particular prediction, enabling a clear understanding of how individual features influence the prediction outcomes.

Results: The XGBoost model achieved an area under the curve (AUC) of 0.95 and an area under the precision-recall curve (AUPR) of 0.76, while CatBoost recorded an AUC of 0.97 and an AUPR of 0.84. These results underscore the effectiveness of these models in predicting DKD in patients with type 2 diabetes.

Conclusions: This study provides a comprehensive approach for predicting DKD in patients with type 2 diabetes, employing machine learning techniques. The findings are crucial for the early detection and intervention of DKD, offering a roadmap for future research and healthcare strategies in diabetes management. Additionally, the presence of non-diabetic kidney diseases and diabetes with complications was identified as significant factors in the development of DKD.

References
1.
. 11. Microvascular Complications and Foot Care: . Diabetes Care. 2020; 44(Suppl 1):S151-S167. DOI: 10.2337/dc21-S011. View

2.
Lundberg S, Erion G, Chen H, DeGrave A, Prutkin J, Nair B . From Local Explanations to Global Understanding with Explainable AI for Trees. Nat Mach Intell. 2020; 2(1):56-67. PMC: 7326367. DOI: 10.1038/s42256-019-0138-9. View

3.
Okada H, Tanaka M, Yasuda T, Okada Y, Norikae H, Fujita T . Peripheral perfusion, measured by perfusion index, is a novel indicator for renal events in patients with type 2 diabetes mellitus. Sci Rep. 2020; 10(1):6054. PMC: 7142064. DOI: 10.1038/s41598-020-62926-8. View

4.
Liabeuf S, Pepin M, Franssen C, Viggiano D, Carriazo S, Gansevoort R . Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?. Nephrol Dial Transplant. 2021; 37(Suppl 2):ii33-ii44. PMC: 8713157. DOI: 10.1093/ndt/gfab223. View

5.
Loftus T, Shickel B, Ozrazgat-Baslanti T, Ren Y, Glicksberg B, Cao J . Artificial intelligence-enabled decision support in nephrology. Nat Rev Nephrol. 2022; 18(7):452-465. PMC: 9379375. DOI: 10.1038/s41581-022-00562-3. View